Rapid Micro Biosystems (RPID) Shareholder's Equity (2020 - 2026)

Rapid Micro Biosystems (RPID) Shareholder's Equity (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 52.06 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 22.98 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 49.20 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 26.10 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 10.33 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 13.34 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 2.96 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 10.67 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 7.20 Bn
10 Rapid Micro Biosystems 77.24 Mn 54.29 Mn 371,000.00 20.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 20.40 Mn
Dec 31, 2025 33.21 Mn
Sep 30, 2025 44.33 Mn
Jun 30, 2025 54.55 Mn
Mar 31, 2025 65.49 Mn
Dec 31, 2024 75.35 Mn
Sep 30, 2024 84.37 Mn
Jun 30, 2024 94.59 Mn
Mar 31, 2024 105.94 Mn
Dec 31, 2023 117.99 Mn
Sep 30, 2023 127.79 Mn
Jun 30, 2023 139.63 Mn
Mar 31, 2023 152.44 Mn
Dec 31, 2022 164.17 Mn
Sep 30, 2022 179.02 Mn
Jun 30, 2022 194.97 Mn
Mar 31, 2022 207.07 Mn
Dec 31, 2021 220.98 Mn
Sep 30, 2021 234.75 Mn
Jun 30, 2021 -164.53 Mn